These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 9375831
1. Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensin-converting enzyme inhibition in hypertensive fawn-hooded rats. Verseput GH, Provoost AP, van Tol A, Koomans HA, Joles JA. Nephron; 1997; 77(3):346-52. PubMed ID: 9375831 [Abstract] [Full Text] [Related]
2. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat. Ochodnický P, Henning RH, Buikema HJ, de Zeeuw D, Provoost AP, van Dokkum RP. Am J Physiol Renal Physiol; 2010 Mar; 298(3):F625-33. PubMed ID: 20007352 [Abstract] [Full Text] [Related]
3. Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids. Doleželová Š, Jíchová Š, Husková Z, Vojtíšková A, Kujal P, Hošková L, Kautzner J, Sadowski J, Červenka L, Kopkan L. Clin Exp Hypertens; 2016 Mar; 38(7):644-651. PubMed ID: 27669111 [Abstract] [Full Text] [Related]
4. Tacrolimus-induced hypertension and nephrotoxicity in Fawn-Hooded rats are attenuated by dual inhibition of renin-angiotensin system. Hošková L, Málek I, Kautzner J, Honsová E, van Dokkum RP, Husková Z, Vojtíšková A, Varcabová S, Cervenka L, Kopkan L. Hypertens Res; 2014 Aug; 37(8):724-32. PubMed ID: 24718302 [Abstract] [Full Text] [Related]
5. Impaired autoregulation of renal blood flow in the fawn-hooded rat. Van Dokkum RP, Alonso-Galicia M, Provoost AP, Jacob HJ, Roman RJ. Am J Physiol; 1999 Jan; 276(1):R189-96. PubMed ID: 9887194 [Abstract] [Full Text] [Related]
6. Renal myogenic constriction protects the kidney from age-related hypertensive renal damage in the Fawn-Hooded rat. Vavrinec P, Henning RH, Goris M, Landheer SW, Buikema H, van Dokkum RP. J Hypertens; 2013 Aug; 31(8):1637-45. PubMed ID: 23811996 [Abstract] [Full Text] [Related]
7. Pathogenesis of glomerular injury in the fawn-hooded rat: early glomerular capillary hypertension predicts glomerular sclerosis. Simons JL, Provoost AP, Anderson S, Troy JL, Rennke HG, Sandstrom DJ, Brenner BM. J Am Soc Nephrol; 1993 May; 3(11):1775-82. PubMed ID: 8329672 [Abstract] [Full Text] [Related]
8. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G. Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013 [Abstract] [Full Text] [Related]
10. Difference in susceptibility of developing renal damage in normotensive fawn-hooded (FHL) and August x Copenhagen Irish (ACI) rats after N(omega)-nitro-L-arginine methyl ester induced hypertension. van Dokkum RP, Jacob HJ, Provoost AP. Am J Hypertens; 1997 Oct; 10(10 Pt 1):1109-16. PubMed ID: 9370381 [Abstract] [Full Text] [Related]
11. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G. Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682 [Abstract] [Full Text] [Related]
12. Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Ruggenenti P, Mise N, Pisoni R, Arnoldi F, Pezzotta A, Perna A, Cattaneo D, Remuzzi G. Circulation; 2003 Feb 04; 107(4):586-92. PubMed ID: 12566371 [Abstract] [Full Text] [Related]
13. Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction. Yatsu T, Sanagi M, Fujimori A, Tomura Y, Hayashi K, Tanahashi M, Inagaki O. Pharmacol Res; 2003 Mar 04; 47(3):243-52. PubMed ID: 12591020 [Abstract] [Full Text] [Related]
14. Altered renal hemodynamics and impaired myogenic responses in the fawn-hooded rat. van Dokkum RP, Sun CW, Provoost AP, Jacob HJ, Roman RJ. Am J Physiol; 1999 Mar 04; 276(3):R855-63. PubMed ID: 10070148 [Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme inhibition in the prevention and treatment of chronic renal damage in the hypertensive fawn-hooded rat. Verseput GH, Provoost AP, Braam BB, Weening JJ, Koomans HA. J Am Soc Nephrol; 1997 Feb 04; 8(2):249-59. PubMed ID: 9048344 [Abstract] [Full Text] [Related]
16. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS. Kidney Int Suppl; 1996 Dec 04; 57():S132-6. PubMed ID: 8941934 [Abstract] [Full Text] [Related]
17. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G. Am J Kidney Dis; 1999 Oct 04; 34(4):626-32. PubMed ID: 10516341 [Abstract] [Full Text] [Related]
18. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO. Afr J Med Med Sci; 2002 Mar 04; 31(1):53-7. PubMed ID: 12518931 [Abstract] [Full Text] [Related]
19. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats. Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH. Eur J Pharmacol; 2008 Feb 02; 580(1-2):231-40. PubMed ID: 18036585 [Abstract] [Full Text] [Related]
20. Effects of renal sympathetic denervation on the course of congestive heart failure combined with chronic kidney disease: Insight from studies with fawn-hooded hypertensive rats with volume overload induced using aorto-caval fistula. Honetschlagerová Z, Škaroupková P, Kikerlová S, Husková Z, Maxová H, Melenovský V, Kompanowska-Jezierska E, Sadowski J, Gawrys O, Kujal P, Červenka L, Čertíková Chábová V. Clin Exp Hypertens; 2021 Aug 18; 43(6):522-535. PubMed ID: 33783285 [Abstract] [Full Text] [Related] Page: [Next] [New Search]